CD14 and Alzheimer disease: In addition, we found that immune cell subsets were uniquely, but to a lesser extent, associated with cognitive decline, as measured by different neuropsychological tests, per AD stage (for example, CD14+ monocytes ~ RAVLT immediate recall, rMCI = -0.64, and rDem = 0.45) (Fig. S5).